Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancer cases and features a strong predilection for early metastasis and extremely poor prognosis. Despite being highly sensitive to chemotherapy and/or radiotherapy initially, most SCLC patients develop therapeutic resistance...
Main Authors: | Jin Yujuan, Chen Yanxu, Qin Zhen, Hu Liang, Guo Chenchen, Ji Hongbin |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2023-05-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2023080 |
Similar Items
-
Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC
by: Yujie Hao, et al.
Published: (2025-01-01) -
Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients
by: Lixia Ju, et al.
Published: (2021-06-01) -
Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC
by: Masaaki Yamamoto, et al.
Published: (2024-09-01) -
Organoids as a Systems Platform for SCLC Brain Metastasis
by: Vito Quaranta, et al.
Published: (2022-04-01) -
Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogram
by: Yanping Su, et al.
Published: (2023-03-01)